SGLT2i use linked to lower risk for neurodegenerative disease in T2DM
By
HealthDay News
Sep 18, 2024
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
Dementia diagnoses up in individuals with acute kidney injury
By
Haymarket Media
Sep 05, 2024
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
To know or not to know, that is the question
By
John O'Connor
Aug 15, 2024
We live in an era where finding answers quickly is highly valued. But is faster always better?
Dementia may occur less often, develop slower in Parkinson’s disease patients
Aug 07, 2024
The median time to dementia was 15 years in the Penn cohort; the estimated probability of dementia at year 10 was 9 to 15% in the PPMI cohort.
Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
Impact of climate change on neurologic health reviewed
Nov 17, 2022
Associations were seen for temperature extremes and variability with stroke and hospitalization for dementia; for airborne pollutants, risk for dementia and Parkinson’s disease.
Regular use of laxatives linked to risk for all-cause dementia
Feb 23, 2023
Risk for all-cause, vascular dementia was increased with number of regularly used laxative types
Road traffic, railway noise linked to increased dementia risk
Sep 10, 2021
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.
3 new dementia studies of note
Oct 27, 2015
New research quantifies costs associated with dementia care compared with other diseases and offers a little good news for those with Lewy body dementia or Alzheimer’s disease.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.